Breakthrough discoveries are advancing understanding and treatment options for neurodegenerative and autoimmune diseases. Studies reveal an autoimmune component in amyotrophic lateral sclerosis, linking inflammatory CD4+ T cells to disease progression. Innovative trial designs target toxic HIV proteins to combat non-suppressible viremia. Investigations into muscle-derived microRNAs highlight regulatory roles in ALS motor neuron health, offering new biomarker and therapeutic avenues.